| |
September 30- October 1, 2024| Boston, MA The Fierce New Product Planning Summit is the only conference focused on how life science professionals make informed, value-based, data-driven decisions about pipeline products. Experts gather annually to discuss resource utilization and key questions for commercial success. Stay Updated! 
|
|
| By Annalee Armstrong Pfizer and Flagship Pioneering have settled on the first target for their billion-dollar, multiprogram collaboration and it’s not exactly a surprise: The New York pharma giant will work with the venture creation firm’s ProFound Therapeutics to develop new obesity drugs. |
|
|
|
By Fraiser Kansteiner Though not for lack of business development capacity, Pfizer is currently taking a large dealmaking “breathing period,” CEO Albert Bourla told investors this week at Goldman Sachs’ 2024 annual Global Healthcare Conference in Miami. |
By Zoey Becker Priya Bhambi, 40, pled guilty to wire fraud charges after running a detailed scheme to scam Takeda into paying for non-existent services from a fake consulting firm. |
By Nick Paul Taylor Biomea Fusion has suffered another dramatic stock drop, with investors sending the share price down 60% after the FDA imposed a full clinical hold on its diabetes program over liver toxicity concerns. |
By Kevin Dunleavy The FDA has approved Geron Corporation's Rytelo (imetelstat) to treat a group of bone marrow disorders called myelodysplastic syndrome (MDS). The approval is the first for the 33-year-old California biotech. |
By Gabrielle Masson Amid an organizational reset, Bayer’s SVP and Global Head of Biotech Jens Vogel, Ph.D., has hit the exits after four years with the German pharma. |
By Nick Paul Taylor Eisai and Biogen’s reign at the top of the Alzheimer’s disease market may be short-lived. While Leqembi is the only game in town today, Bloomberg Intelligence analysts expect Eli Lilly to come from behind and capture half of a $13 billion market by 2030. |
By Zoey Becker The BIOSECURE Act was officially left off of the National Defense Authorization Act (NDAA), which was the expected first step to the bill's passage. |
By Conor Hale After previewing its agreement earlier this year, laparoscopic robotics developer Asensus Surgical has made its buyout official. |
By Helen Floersh Against a backdrop of low-volume but growing concerns about bird flu, the National Institutes of Health’s infectious disease arm has laid out its plans to study the virus that causes the illness. |
Fierce podcasts Don’t miss an episode |
| In this week’s episode of “Podnosis”, Senior Writer Paige Minemyer sits down with Clearwater CEO Steve Cagle to explore the lessons healthcare organizations can learn from the Change Healthcare cyberattack and what it reveals about the industry’s current state of security readiness. |
|
|---|
|
|
|
July 8-9, 2024 | Jersey City, NJ Hear the latest industry trends from leaders in the field, and developed with input from our esteemed advisory board, to ensure you have a sound plan for your company, brands, and yourself.
Save $200 when you Register Today! +(1).png)
|
|
Whitepaper This study delved into the manufacturing costs of the three mRNA capping methods. It involved discussions with 30 subject matter experts engaged in mRNA therapeutic development across various companies in the US and the EU. Sponsored by: TriLink |
eBook An insider’s workbook filled with practical tips and tools for designing and scaling a global patient support program. Sponsored by: Harte Hanks |
Webinar Watch our on-demand webinar video to learn more about the challenges in pDNA manufacturing for gene and cell therapy and how to resolve many of these barriers by partnering with our experts through the adoption of vital manufacturing technologies and strategies. Sponsored by: Aldevron |
Research Learn how a Top-10 Pharma company automated the extraction of oncology efficacy endpoints from scientific literature with high precision and recall using a combination of AI technologies. Sponsored by: IQVIA |
eBook This eBook offers insights for business leaders looking to do more with reduced budgets by using the power of SmartIQ’s true forms automation to eliminate the need to print, sign, and scan/mail physical documents, increase operational efficiency, and reduce disparate systems. Sponsored by: SmartComms LLC |
Research Download this research report to discover how a new predictive model built on consumer attitudinal data can generate improved results for health marketers. Sponsored by: Quad Media |
Whitepaper Virtual care programs represent a compelling opportunity for decision makers in life sciences companies to drive growth, innovation, and value creation. Download now to learn more. Sponsored by: Wheel |
Whitepaper Small molecule active pharmaceutical ingredients (APIs) continue to grow more complex. Download the white paper to learn more about using synthesis and route design technology to approach API complexity. Sponsored by: Lonza |
Whitepaper This paper outlines the challenges, pitfalls, & solutions associated with adding rare disease therapies to a biopharma company’s portfolio. Sponsored by: AIM, the strategic leader in life science supply chains |
On Helix Date: 4 July 2024 - Location: Babraham Research Campus, Cambridge UK |
|
| |
|
